
|Articles|June 15, 2012
Webinar Skin Disorders Multiplayer
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Health system–based clinical pathway improves pediatric lipid screening rates
2
Julie Khlevner, MD, AGAF, explains the impact of the FDA approval of linaclotide for pediatric IBS-C
3
Linaclotide demonstrates positive long-term safety
4
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
5














